702 filings
Page 17 of 36
SC TO-C
dt55 0be5n1
17 Feb 16
Information about tender offer
12:00am
8-K
namn9yyiklpqf4ij6ay
11 Feb 16
Results of Operations and Financial Condition
12:00am
8-K
1qclw7h1shsb
25 Jan 16
Unregistered Sales of Equity Securities
12:00am
8-K
8686mfbk
20 Jan 16
Other Events
12:00am
8-K
wmopjc ua0
19 Jan 16
Acorda to Acquire Biotie Therapies
12:00am
SC TO-C
2uf2gei0uv1k2suifhpt
19 Jan 16
Information about tender offer
12:00am
SC TO-C
jgr65qctpl0n kw8
19 Jan 16
Information about tender offer
12:00am
8-K
0feqt2 l3z1dv
11 Jan 16
Acorda Announces 2015 AMPYRA Sales, 2016 Financial Guidance and 2016/2017 Clinical Milestones at J.P. Morgan Healthcare Conference
12:00am
8-K
641see9saiqon
21 Dec 15
Acorda Announces Departure of Chief Medical Officer (CMO); Company Appoints Burkhard Blank, M.D. as Interim CMO
12:00am
8-K
tcixp3a573n8w1e6dxb
10 Dec 15
Other Events
12:00am
8-K
sx7e3 14u1c1e
8 Dec 15
Acorda Presents Analyses on Use of Healthcare Services for Seizure Clusters at American Epilepsy Society Annual Meeting
12:00am
8-K
0qw5mi84565oo15nab7
3 Dec 15
Other Events
12:00am
8-K
0ulhln
22 Oct 15
Acorda Provides Financial and Pipeline Update for 2015 Third Quarter
12:00am
8-K
xxl k0f9yi4gv8g7gnb
21 Oct 15
Other Events
12:00am
8-K
ygnhe
7 Oct 15
Other Events
12:00am
CT ORDER
zoe8 tivqr
6 Oct 15
Confidential treatment order
12:00am
8-K
2xdlm06
5 Oct 15
Other Events
12:00am
8-K
klayezwvbu1mx5yn9tn
3 Sep 15
Other Events
12:00am
8-K
1i25 sp93u
25 Aug 15
Acorda Announces Patent Trials and Appeal Board (PTAB) Denies Both IPRs of AMPYRA Patents
12:00am